Our mission is to develop drugs that attack the most aggressive human cancers. We aim for transformative medicines that will make a large difference for patients.
Our drug development is science-driven. Tradewind was formed to translate science developed by its founders into novel drugs, so we bring expertise, assays and proprietary knowledge to the table.
We couple our drug development with a focus on biomarker identification. We aim to pick out the patients that will benefit most from the medicines we are developing.
Copyright © 2021 Tradewind BioScience - All Rights Reserved.